IL24 and malignant colon neoplasm: Additionally, administration of IL‐24 reconfigured the TME (tumor microenvironment) in murine colon cancer models, with a higher percentage of CD45+ CD4+ and CD45+ CD8+ cells and a decrease in CD45+ CD4+ Foxp3+ cells, suggestive of a type I immune response.